Levels of complement in sera from inactive SLE patients, although decreased, do not influence in vitro uptake of apoptotic cells

In most SLE patients with inactive disease, levels of one or more complement components are decreased. However, decreased levels of complement do not result in a significantly reduced in vitro uptake of apoptotic Jurkat cells by MDM.